Answer
Pasireotide diaspartate may decrease ciclosporin’s relative bioavailability, so concomitant administration may require adjustment of the ciclosporin dose to maintain therapeutic levels.
Sources for this answer
- Signifor 0.3 mg solution for injectionRecordati Rare Diseases UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 18Document updated
Sources checked